EDAP TMS SAEDAP财报
Nasdaq
EDAP TMS SA is a global medical technology company specializing in the development, manufacturing, and distribution of minimally invasive urology care solutions, most notably high-intensity focused ultrasound (HIFU) devices for benign prostatic hyperplasia and prostate cancer treatment. It serves healthcare providers across Europe, North America, and the Asia-Pacific region.
What changed in EDAP TMS SA's 6-K — 2022 vs 2023
No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.